Everything below concerns anti-doping analysis. We keep the language plain, cite what the science says, and separate well-supported claims from open questions.
Updated 2026-03-28. Numbers and descriptions here follow the published literature rather than marketing material.
A central uncertainty is whether observed metabolic changes translate into meaningful clinical benefits. Study designs vary in dose, duration, and participant characteristics, making comparisons difficult. Independent replication is limited, and the field lacks consensus on optimal endpoints or treatment duration. Ongoing or future studies may clarify mechanism and effect size, but current evidence does not establish a clear therapeutic role. Researchers often call for larger, longer, and better-controlled trials, while questions remain about which patient groups might respond.
Proposed mechanism focuses on lipolysis, the breakdown of stored triglycerides into free fatty acids and glycerol. AOD-9604 is thought to act on adipose tissue without stimulating appetite or affecting blood sugar in the same way as growth hormone. Laboratory studies report increased fat oxidation in some models. The precise receptor interactions and signaling pathways remain incompletely characterized. Researchers have proposed that the peptide may influence fat mobilization through pathways distinct from the full hormone.
Regulatory interest in AOD-9604 increased after high-profile anti-doping cases involving peptide products. In some cases, the substance was supplied under alternative names or in compounded preparations, complicating traceability. Sports tribunals and anti-doping panels have discussed whether the peptide was explicitly banned at the time of use, leading to clarifications by the World Anti-Doping Agency. For consumers and researchers, the legal status can vary by jurisdiction, and products marketed as research chemicals may lack independent quality verification.
AOD-9604 is listed as a prohibited substance in sport by the World Anti-Doping Agency. It falls under the peptide hormones, growth factors, related substances, and mimetics class on the prohibited list. Anti-doping organizations treat its presence in an athlete's sample as an adverse finding unless a therapeutic use exemption applies. The prohibition reflects concerns about performance enhancement in competitive settings and the difficulty of distinguishing exogenous peptide use from endogenous hormone fragments.
| Property | Value | Notes |
|---|---|---|
| Chemical class | Synthetic peptide fragment | Not a full hormone |
| Molecular target | Proposed adipose tissue lipolysis | Receptor details uncertain |
| Typical research dose | Not established for clinical use | Doses vary across studies |
| Stability in solution | Limited; store cold | Avoid repeated freeze-thaw |
| Regulatory status | Not approved as a drug | Varies by country |
Imperatoxin A (activator): a peptide toxin which enhances the influx of Ca2+ from the sarcoplasmatic reticulum into the cell. Imperatoxin I (inhibitor): a peptide toxin which decreases the influx of Ca2+ from the sarcoplasmatic reticulum into the cell.
As of 2017, lithium was marketed under many brand names worldwide, including Cade, Calith, Camcolit, Carbolim, Carbolit, Carbolith, Carbolithium, Carbonato de Litio, Carboron, Ceglution, Contemnol, Efadermin (Lithium and Zinc Sulfate), Efalith (Lithium and Zinc Sulfate), Elcab, Eskalit, Eskalith, Frimania, Hypnorex, Kalitium, Karlit, Lalithium, Li-Liquid, Licarb, Licarbium, Lidin, Ligilin, Lilipin, Lilitin, Limas, Limed, Liskonum, Litarex, Lithane, Litheum, Lithicarb, Lithii carbonas, Lithii citras, Lithioderm, Lithiofor, Lithionit, Lithium, Lithium aceticum, Lithium asparagicum, Lithium Carbonate, Lithium Carbonicum, Lithium Citrate, Lithium DL-asparaginat-1-Wasser, Lithium gluconicum, Lithium-D-gluconat, Lithiumcarbonaat, Lithiumcarbonat, Lithiumcitrat, Lithiun, Lithobid, Lithocent, Lithotabs, Lithuril, Litiam, Liticarb, Litijum, Litio, Litiomal, Lito, Litocarb, Litocip, Maniprex, Milithin, Neurolepsin, Plenur, Priadel, Prianil, Prolix, Psicolit, Quilonium, Quilonorm, Quilonum, Sedalit, Téralithe, and Theralite. Lithium is available as lithium carbonate in tablets or capsules, and as lithium citrate in liquid form. In the United States, standard release tablets are available in 300 mg. Standard release capsules come in strengths of 150 mg, 300 mg, and 600 mg. Slow release tablets are available in 300 mg and 450 mg. Liquid lithium, in the form of lithium citrate, is available as an 8 mEq/5 mL solution. In the United Kingdom, lithium is available as standard release tablets of 250 mg, while slow release tablets come in 200 mg, 400 mg and 450 mg.
=== Early life === Frederik Dag Arfst Paulsen was born on 30 October 1950 in Stockholm, Sweden, as a Swedish citizen. His father was Frederik Paulsen Sr, the founder of Ferring Pharmaceuticals. Paulsen grew up in Sweden, with his father and his father's second wife, Dr. Eva Wolf Frandsen – one of the founding researchers at Ferring. He attended school in Sweden and then went on to study chemistry at the Christian Albrecht University in Kiel, (Germany) and business administration at Lund University in Sweden. He received his doctoral degree in Demography from Ecole des Hautes Etudes en Sciences Sociales in Paris, France.
The fifth season had twelve roles receiving star billing, with eleven of them returning from the previous season, eight of which part of the original cast from the first season, and three new cast members being added. Kerry Washington continued to play her role as protagonist of the series, Olivia Pope, a former White House Director of Communications with her own crisis management firm. Darby Stanchfield played Abby Whelan, the White House Press Secretary, Katie Lowes portrayed Quinn Perkins, and Guillermo Diaz portrayed Huck, the troubled tech guy who works for Olivia. Cornelius Smith Jr. continued his role as activist Marcus Walker. after being upgraded to series regular. Jeff Perry continued to portray Cyrus Beene, chief of staff at the White House who was fired by Fitz but later rehired. Portia de Rossi played Elizabeth North, the new chief of staff at the White House, and later the chief of staff for the vice president. Joshua Malina played the role of David Rosen, former U.S. Attorney, now Attorney General. Bellamy Young continued to act as First Lady/Senator Melody "Mellie" Grant, who was kicked out of the White House by Fitz, and later joined the presidential campaign for president. Tony Goldwyn continued to portray President Fitzgerald "Fitz" Thomas Grant III. Scott Foley portrayed Jake Ballard a former B613 agent and later the head of the NSA. On May 14, 2015, after the fourth-season finale, it was announced that Portia de Rossi had been promoted to a series regular for the fifth season.
In 1910, Hahn was appointed professor by the Prussian Minister of Culture and Education, August von Trott zu Solz. Two years later, Hahn became head of the Radioactivity Department of the newly founded Kaiser Wilhelm Institute for Chemistry (KWIC) in Berlin-Dahlem (in what is today the Hahn-Meitner-Building of the Free University of Berlin). This came with an annual salary of 5,000 marks (equivalent to €29,000 in 2021). In addition, he received 66,000 marks in 1914 (equivalent to €369,000 in 2021) from Knöfler for the mesothorium process, of which he gave 10 per cent to Meitner. The new institute was inaugurated on 23 October 1912 in a ceremony presided over by Kaiser Wilhelm II. The Kaiser was shown glowing radioactive substances in a dark room. The move to new accommodation was fortuitous, as the wood shop had become heavily contaminated by radioactive liquids that had been spilt, and radioactive gases that had vented and then decayed and settled as radioactive dust, making sensitive measurements impossible. To ensure that their clean new laboratories stayed that way, Hahn and Meitner instituted strict procedures. Chemical and physical measurements were conducted in different rooms, people handling radioactive substances had to follow protocols that included not shaking hands, and rolls of toilet paper were hung next to every telephone and door handle. Strongly radioactive substances were stored in the old wood shop, and later in a purpose-built radium house on the institute grounds.
Sources: en.wikipedia.org
=== Weaning === During weaning, decreased prolactin, missing mechanical stimulation (baby suckling), and changes in osmotic balance caused by milk stasis and leaking of tight junctions cause cessation of milk production. It is the (passive) process of a child or animal ceasing to be dependent on the mother for nourishment. In some species there is complete or partial involution of alveolar structures after weaning, in humans there is only partial involution and the level of involution in humans appears to be highly individual. The glands in the breast do secrete fluid also in nonlactating women. In some other species (such as cows), all alveoli and secretory duct structures collapse by programmed cell death (apoptosis) and autophagy for lack of growth promoting factors either from the ECM or circulating hormones. At the same time, apoptosis of blood capillary endothelial cells speeds up the regression of lactation ductal beds. Shrinkage of the mammary duct tree and ECM remodeling by various proteinase is under the control of somatostatin and other growth inhibiting hormones and local factors. This major structural change leads loose fat tissue to fill the empty space afterward. But a functional lactiferous duct tree can be formed again when a female is pregnant again.
== Limitations of MRS == The major limitation to MRS is its low available signal due to the low concentration of metabolites as compared to water. As such, it has inherently poor temporal and spatial resolution. Nevertheless, no alternate technique is able to quantify metabolism in vivo non-invasively and thus MRS remains a valuable tool for research and clinical scientists. In addition, despite recent efforts toward international expert consensus on methodological details like shimming, motion correction, spectral editing, spectroscopic neuroimaging, other advanced acquisition methods, data processing and quantification, application to brain, proton spectroscopy application to skeletal muscle, phosphorus application to skeletal muscle, methods description, results reporting, and other considerations, currently published implementations of in vivo magnetic resonance spectroscopy cluster into literatures exhibiting a broad variety of individualized acquisition, processing, quantification, and reporting techniques. This situation may contribute to a low sensitivity and specificity of, for example, in vivo proton magnetic resonance spectroscopy to disorders such as multiple sclerosis, that continue to fall below clinically beneficial thresholds for, e.g., diagnosis.
==== Declined ==== Genevieve Collins, business executive and nominee for this district in 2020 Darrell Issa, incumbent U.S. representative from California's 48th congressional district Eric Johnson, mayor of Dallas (2019–present) Katrina Pierson, state representative from the 33rd district (2025–present) and candidate for this district in 2014 (running for re-election)
== Companies and organizations == Companies such as Google, Microsoft and Amazon Web Services have offered platforms for deploying pre-built AI agents. Several protocols have been proposed for standardizing inter-agent communication, such as Agent2Agent, Gibberlink, and others. In December 2025, Linux Foundation announced the formation of the Agentic AI Foundation (AAIF), with the goal of ensuring that agentic AI evolves transparently and collaboratively.
Sources: en.wikipedia.org
It is proposed to promote lipolysis in fat tissue, the breakdown of stored fat into fatty acids and glycerol. The detailed receptor and signaling mechanisms are not fully established.
Because it is a fragment rather than full growth hormone, it is generally described as lacking growth-promoting effects. Some studies suggest it may influence fat metabolism without the same systemic growth effects, though evidence is limited.
Human trials have measured body weight, fat mass, lean mass, lipid levels, and adverse events. Most have been small or short-term, so conclusions about long-term outcomes are limited.
Yes, the World Anti-Doping Agency classifies AOD-9604 as a prohibited peptide hormone and related substance. Its use by athletes is banned under the relevant anti-doping code.